Stock Research for AKRX

AKRX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AKRX Stock Chart & Research Data

The AKRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AKRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AKRX Due diligence Resources & Stock Charts

The AKRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AKRX Detailed Price Forecast - CNN Money CNN View AKRX Detailed Summary - Google Finance
Yahoo View AKRX Detailed Summary - Yahoo! Finance Zacks View AKRX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AKRX Trends & Analysis - Trade-Ideas Barrons View AKRX Major Holders - Barrons
NASDAQ View AKRX Call Transcripts - NASDAQ Seeking View AKRX Breaking News & Analysis - Seeking Alpha
Spotlight View AKRX Annual Report - CompanySpotlight.com OTC Report View AKRX OTC Short Report - OTCShortReport.com
TradeKing View AKRX Fundamentals - TradeKing Charts View AKRX SEC Filings - Bar Chart
WSJ View Historical Prices for AKRX - The WSJ Morningstar View Performance/Total Return for AKRX - Morningstar
MarketWatch View the Analyst Estimates for AKRX - MarketWatch CNBC View the Earnings History for AKRX - CNBC
StockMarketWatch View the AKRX Earnings - StockMarketWatch MacroAxis View AKRX Buy or Sell Recommendations - MacroAxis
Bullish View the AKRX Bullish Patterns - American Bulls Short Pains View AKRX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AKRX Stock Mentions - StockTwits PennyStocks View AKRX Stock Mentions - PennyStockTweets
Twitter View AKRX Stock Mentions - Twitter Invest Hub View AKRX Investment Forum News - Investor Hub
Yahoo View AKRX Stock Mentions - Yahoo! Message Board Seeking Alpha View AKRX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AKRX - SECform4.com Insider Cow View Insider Transactions for AKRX - Insider Cow
CNBC View AKRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AKRX - OTC Markets
Yahoo View Insider Transactions for AKRX - Yahoo! Finance NASDAQ View Institutional Holdings for AKRX - NASDAQ


Stock Charts

FinViz View AKRX Stock Insight & Charts - FinViz.com StockCharts View AKRX Investment Charts - StockCharts.com
BarChart View AKRX Stock Overview & Charts - BarChart Trading View View AKRX User Generated Charts - Trading View




Latest Financial News for AKRX


RBC Is Bullish on Generic Pharma: Upgrades MYL, AMRX, ENDO, AKRX
Posted on Monday August 13, 2018

RBC Is Bullish on Generic Pharma: Upgrades MYL, AMRX, ENDO, AKRXRBC updates its view on the generic pharma industry


See what the IHS Markit Score report has to say about Akorn Inc.
Posted on Thursday August 09, 2018

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.


Factors of Influence in 2018, Key Indicators and Opportunity within Five Prime Therapeutics, Akorn, The Blackstone Group, Avaya, Tractor Supply, and CymaBay Therapeutics — New Research Emphasizes Economic Growth
Posted on Wednesday August 01, 2018

NEW YORK, Aug. 01, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Five ...


Complimentary Technical Snapshots on Akorn and Three More Generic Drugs Stocks
Posted on Tuesday July 31, 2018

WallStEquities.com revisits the Generic Drugs market, which can be segmented into biosimilars, simple generic, and super generic. Based on its therapeutics applications, the generic drugs market can be classified into cardiovascular products, anti-infective drugs, anti-arthritis drugs, central nervous system drugs, anti-cancer drugs, respiratory products, and others. Under assessment this morning are these four stocks: Agile Therapeutics Inc. (NASDAQ: AGRX), Akorn Inc. (NASDAQ: AKRX), Collegium Pharmaceutical Inc. (NASDAQ: COLL), and Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX).


Stock Market & Investing Books

Enter a stock symbol to view the stock details.